Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer

This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) in endometrial carcinoma (EC). BUB1 and BUBIB expressions were evaluated by bioinformatics. Protein expression, clinica...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Scientific reports Ročník 14; číslo 1; s. 17084 - 11
Hlavní autoři:	Zhang, Huicong, li, yuhao, Lu, Huixia
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 24.07.2024 Nature Publishing Group Nature Portfolio
Témata:	631/114 631/67 Benzimidazoles Bioinformatics Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism BUB1 BUB1B Cancer CD4 antigen CD8 antigen Cell Cycle Proteins Cell Line, Tumor Cell migration Cell Movement - genetics Clinicopathological characteristics Development Disease-Free Survival Endometrial cancer Endometrial Neoplasms - genetics Endometrial Neoplasms - mortality Endometrial Neoplasms - pathology Endometrium Endothelial cells Female Gene expression Gene Expression Regulation, Neoplastic Humanities and Social Sciences Humans Immunotherapy Infiltration Kinases Lymphocytes T Medical prognosis Metastases Middle Aged multidisciplinary Phenotypes Prognosis Protein Serine-Threonine Kinases - genetics Protein Serine-Threonine Kinases - metabolism Protein-serine/threonine kinase Science Science (multidisciplinary) siRNA Uterine cancer Development BUB1B Clinicopathological characteristics Prognosis Endometrial cancer BUB1
ISSN:	2045-2322, 2045-2322
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) in endometrial carcinoma (EC). BUB1 and BUBIB expressions were evaluated by bioinformatics. Protein expression, clinical features, prognosis and immune cell infiltration were explored in 20 EC tumors. siRNA was used to evaluate BUB1 and BUBIB function in EC cells. BUB1 and BUBIB were highly expressed in 26 cancers. BUB1 was associated with overall survival (OS) in eight cancers and disease-free survival in ten; BUB1B was associated with OS in nine cancers and DFS in eleven. BUB1 and BUBIB exhibited high frequencies of gene changes (mainly mutations, > 5%) in cancer. BUB1 was negatively correlated and BUB1B was positively correlated with cancer-associated fibroblasts and endothelial cell infiltration. BUB1 and BUBIB knockdown decreased migration and invasion in EC cells. High BUB1 expression correlated with tumor malignant phenotypes ( P < 0.05). High BUB1 mRNA expression reduced OS ( P = 0.00036) and recurrence-free survival ( P = 0.0011). High BUB1B mRNA expression reduced OS ( P = 0.0024). BUB1/BUB1B correlated with activated CD8 + T and CD4 + T cell infiltration. BUB1 and BUBIB are highly expressed and correlated with clinicopathological characteristics in EC. BUB1 and BUBIB are potential prognosis markers and immunotherapy targets.
AbstractList	This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) in endometrial carcinoma (EC). BUB1 and BUBIB expressions were evaluated by bioinformatics. Protein expression, clinical features, prognosis and immune cell infiltration were explored in 20 EC tumors. siRNA was used to evaluate BUB1 and BUBIB function in EC cells. BUB1 and BUBIB were highly expressed in 26 cancers. BUB1 was associated with overall survival (OS) in eight cancers and disease-free survival in ten; BUB1B was associated with OS in nine cancers and DFS in eleven. BUB1 and BUBIB exhibited high frequencies of gene changes (mainly mutations, > 5%) in cancer. BUB1 was negatively correlated and BUB1B was positively correlated with cancer-associated fibroblasts and endothelial cell infiltration. BUB1 and BUBIB knockdown decreased migration and invasion in EC cells. High BUB1 expression correlated with tumor malignant phenotypes ( P < 0.05). High BUB1 mRNA expression reduced OS ( P = 0.00036) and recurrence-free survival ( P = 0.0011). High BUB1B mRNA expression reduced OS ( P = 0.0024). BUB1/BUB1B correlated with activated CD8 + T and CD4 + T cell infiltration. BUB1 and BUBIB are highly expressed and correlated with clinicopathological characteristics in EC. BUB1 and BUBIB are potential prognosis markers and immunotherapy targets. This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) in endometrial carcinoma (EC). BUB1 and BUBIB expressions were evaluated by bioinformatics. Protein expression, clinical features, prognosis and immune cell infiltration were explored in 20 EC tumors. siRNA was used to evaluate BUB1 and BUBIB function in EC cells. BUB1 and BUBIB were highly expressed in 26 cancers. BUB1 was associated with overall survival (OS) in eight cancers and disease-free survival in ten; BUB1B was associated with OS in nine cancers and DFS in eleven. BUB1 and BUBIB exhibited high frequencies of gene changes (mainly mutations, > 5%) in cancer. BUB1 was negatively correlated and BUB1B was positively correlated with cancer-associated fibroblasts and endothelial cell infiltration. BUB1 and BUBIB knockdown decreased migration and invasion in EC cells. High BUB1 expression correlated with tumor malignant phenotypes (P < 0.05). High BUB1 mRNA expression reduced OS (P = 0.00036) and recurrence-free survival (P = 0.0011). High BUB1B mRNA expression reduced OS (P = 0.0024). BUB1/BUB1B correlated with activated CD8 + T and CD4 + T cell infiltration. BUB1 and BUBIB are highly expressed and correlated with clinicopathological characteristics in EC. BUB1 and BUBIB are potential prognosis markers and immunotherapy targets.This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) in endometrial carcinoma (EC). BUB1 and BUBIB expressions were evaluated by bioinformatics. Protein expression, clinical features, prognosis and immune cell infiltration were explored in 20 EC tumors. siRNA was used to evaluate BUB1 and BUBIB function in EC cells. BUB1 and BUBIB were highly expressed in 26 cancers. BUB1 was associated with overall survival (OS) in eight cancers and disease-free survival in ten; BUB1B was associated with OS in nine cancers and DFS in eleven. BUB1 and BUBIB exhibited high frequencies of gene changes (mainly mutations, > 5%) in cancer. BUB1 was negatively correlated and BUB1B was positively correlated with cancer-associated fibroblasts and endothelial cell infiltration. BUB1 and BUBIB knockdown decreased migration and invasion in EC cells. High BUB1 expression correlated with tumor malignant phenotypes (P < 0.05). High BUB1 mRNA expression reduced OS (P = 0.00036) and recurrence-free survival (P = 0.0011). High BUB1B mRNA expression reduced OS (P = 0.0024). BUB1/BUB1B correlated with activated CD8 + T and CD4 + T cell infiltration. BUB1 and BUBIB are highly expressed and correlated with clinicopathological characteristics in EC. BUB1 and BUBIB are potential prognosis markers and immunotherapy targets. This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) in endometrial carcinoma (EC). BUB1 and BUBIB expressions were evaluated by bioinformatics. Protein expression, clinical features, prognosis and immune cell infiltration were explored in 20 EC tumors. siRNA was used to evaluate BUB1 and BUBIB function in EC cells. BUB1 and BUBIB were highly expressed in 26 cancers. BUB1 was associated with overall survival (OS) in eight cancers and disease-free survival in ten; BUB1B was associated with OS in nine cancers and DFS in eleven. BUB1 and BUBIB exhibited high frequencies of gene changes (mainly mutations, > 5%) in cancer. BUB1 was negatively correlated and BUB1B was positively correlated with cancer-associated fibroblasts and endothelial cell infiltration. BUB1 and BUBIB knockdown decreased migration and invasion in EC cells. High BUB1 expression correlated with tumor malignant phenotypes (P < 0.05). High BUB1 mRNA expression reduced OS (P = 0.00036) and recurrence-free survival (P = 0.0011). High BUB1B mRNA expression reduced OS (P = 0.0024). BUB1/BUB1B correlated with activated CD8 + T and CD4 + T cell infiltration. BUB1 and BUBIB are highly expressed and correlated with clinicopathological characteristics in EC. BUB1 and BUBIB are potential prognosis markers and immunotherapy targets. Abstract This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) in endometrial carcinoma (EC). BUB1 and BUBIB expressions were evaluated by bioinformatics. Protein expression, clinical features, prognosis and immune cell infiltration were explored in 20 EC tumors. siRNA was used to evaluate BUB1 and BUBIB function in EC cells. BUB1 and BUBIB were highly expressed in 26 cancers. BUB1 was associated with overall survival (OS) in eight cancers and disease-free survival in ten; BUB1B was associated with OS in nine cancers and DFS in eleven. BUB1 and BUBIB exhibited high frequencies of gene changes (mainly mutations, > 5%) in cancer. BUB1 was negatively correlated and BUB1B was positively correlated with cancer-associated fibroblasts and endothelial cell infiltration. BUB1 and BUBIB knockdown decreased migration and invasion in EC cells. High BUB1 expression correlated with tumor malignant phenotypes (P < 0.05). High BUB1 mRNA expression reduced OS (P = 0.00036) and recurrence-free survival (P = 0.0011). High BUB1B mRNA expression reduced OS (P = 0.0024). BUB1/BUB1B correlated with activated CD8 + T and CD4 + T cell infiltration. BUB1 and BUBIB are highly expressed and correlated with clinicopathological characteristics in EC. BUB1 and BUBIB are potential prognosis markers and immunotherapy targets.
ArticleNumber	17084
Author	Zhang, Huicong li, yuhao Lu, Huixia
Author_xml	– sequence: 1 givenname: Huicong surname: Zhang fullname: Zhang, Huicong organization: Clinical Medicinal College of Dali University – sequence: 2 givenname: yuhao surname: li fullname: li, yuhao organization: West China School of Basic Medical Sciences and Forensic Medicine,, Sichuan University – sequence: 3 givenname: Huixia surname: Lu fullname: Lu, Huixia email: Haohao021021@foxmail.com organization: Clinical Medicinal College of Dali University, Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/39048649$$D View this record in MEDLINE/PubMed
BookMark	eNp9UstuEzEUHaEiWkp_gAUaiQ2bAb8fK0QiHpUqsaFsLY99J3E0sYM9KeLvcSYttF3UkuUr33OOjn3Py-YkpghN8xqj9xhR9aEwzLXqEGGdkJyojjxrzghivCOUkJN79WlzUcoG1cWJZli_aE6pRkwJps-an8uUM4x2Cim2aWgX1wvc2ujnYtH-DtO6ndbQeriBMe22EKe5vctpFVMJ5UCC6NMWphzs2DobHeRXzfPBjgUubs_z5vrL5x_Lb93V96-Xy09XneMMTx2xiAIXVPS0p5qBFWoYlCBsGAboJeeWMOkVUE6wVw740AsHIJFQXmqP6XlzedT1yW7MLoetzX9MssHMFymvjM1TcCOYnhDpEXVM2cMmVmnPes29k72mvahaH49au32_Be_qU7MdH4g-7MSwNqt0YzAmQkvEqsK7W4Wcfu2hTGYbioNxtBHSvhiKFJNCSsYr9O0j6Cbtc6x_NaMwklQeBN_ct_TPy938KkAdAS6nUjIMxoVpHmZ1GEaDkTmkxRzTYmpazJwWQyqVPKLeqT9JokdSqeC4gvzf9hOsv4_20Ks
CitedBy_id	crossref_primary_10_1007_s12672_024_01712_8 crossref_primary_10_1016_j_intimp_2024_113810 crossref_primary_10_3390_ijms252212356 crossref_primary_10_1371_journal_pone_0324337 crossref_primary_10_3389_fped_2025_1624671 crossref_primary_10_3390_ijms26052061 crossref_primary_10_1007_s12032_025_02976_y
Cites_doi	10.1002/path.6012 10.2147/CMAR.S337271 10.3892/mmr.2021.12155 10.1016/j.tibs.2010.08.004 10.1186/s12864-016-2904-y 10.31557/APJCP.2023.24.5.1797 10.3322/caac.21660 10.1111/jcmm.15408 10.3390/biomedicines9060632 10.1038/nrc1714 10.1186/s13046-021-02179-z 10.1016/j.celrep.2018.03.100 10.1186/s13048-019-0508-2 10.3322/caac.21561 10.1097/MD.0000000000027305 10.1080/15384047.2020.1840318 10.1002/path.1324 10.15252/embr.202050257 10.1038/s41586-020-03114-6 10.1155/2022/5721630 10.18632/oncotarget.3944 10.1038/s41419-020-03234-x 10.1080/19768354.2021.1884599 10.1016/j.tjog.2021.09.007 10.1158/0008-5472.CAN-09-4319 10.1053/j.gastro.2013.06.001 10.1007/s10577-020-09646-x 10.1002/1098-2264(2000)9999:9999<::AID-GCC1027>3.0.CO;2-G 10.1016/j.ejphar.2018.07.034 10.18632/oncotarget.10657 10.1371/journal.pcbi.1011122 10.1152/physrev.00048.2019 10.1042/BSR20211719 10.1002/gcc.22385 10.1080/21655979.2021.2013108 10.1007/s12032-015-0542-x 10.1155/2014/145289 10.1155/2022/3217248 10.1038/s41423-020-0488-6 10.1186/s13059-016-1028-7
ContentType	Journal Article
Copyright	The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024
Copyright_xml	– notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA
DOI	10.1038/s41598-024-67528-2
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	CrossRef MEDLINE - Academic MEDLINE Publicly Available Content Database
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2045-2322
EndPage	11
ExternalDocumentID	oai_doaj_org_article_b227d03c48ac48a2a89d4b95dc7b93b6 PMC11269704 39048649 10_1038_s41598_024_67528_2
Genre	Journal Article
GrantInformation_xml	– fundername: “Master’s Scientific Fund Project of the Education Department of Yunnan Province grantid: 2022Y860 – fundername: Dali University research and development Fund grantid: FZ2023YB036 – fundername: "Master's Scientific Fund Project of the Education Department of Yunnan Province grantid: 2022Y860
GroupedDBID	0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFFHD AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI Q9U 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c541t-2a03e5636b3b394ea68ff8624fffeb755a247d8e3521d8ce5fb6cee7068d79d13
IEDL.DBID	DOA
ISICitedReferencesCount	9
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001276798400030&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2045-2322
IngestDate	Mon Nov 10 04:30:14 EST 2025 Tue Nov 04 02:06:00 EST 2025 Thu Oct 02 11:03:09 EDT 2025 Tue Oct 07 08:25:29 EDT 2025 Mon Jul 21 06:05:04 EDT 2025 Tue Nov 18 22:49:44 EST 2025 Sat Nov 29 02:13:40 EST 2025 Fri Feb 21 02:40:06 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Development BUB1B Clinicopathological characteristics Prognosis Endometrial cancer BUB1
Language	English
License	2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c541t-2a03e5636b3b394ea68ff8624fffeb755a247d8e3521d8ce5fb6cee7068d79d13
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://doaj.org/article/b227d03c48ac48a2a89d4b95dc7b93b6
PMID	39048649
PQID	3084107374
PQPubID	2041939
PageCount	11
ParticipantIDs	doaj_primary_oai_doaj_org_article_b227d03c48ac48a2a89d4b95dc7b93b6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11269704 proquest_miscellaneous_3084767745 proquest_journals_3084107374 pubmed_primary_39048649 crossref_citationtrail_10_1038_s41598_024_67528_2 crossref_primary_10_1038_s41598_024_67528_2 springer_journals_10_1038_s41598_024_67528_2
PublicationCentury	2000
PublicationDate	2024-07-24
PublicationDateYYYYMMDD	2024-07-24
PublicationDate_xml	– month: 07 year: 2024 text: 2024-07-24 day: 24
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Scientific reports
PublicationTitleAbbrev	Sci Rep
PublicationTitleAlternate	Sci Rep
PublicationYear	2024
Publisher	Nature Publishing Group UK Nature Publishing Group Nature Portfolio
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio
References	Gemma (CR30) 2000; 29 Brooks (CR9) 2019; 69 Pierantoni (CR29) 2015; 6 Wu, Zang, Xing, Dai (CR45) 2021; 36 Teixeira (CR32) 2014; 2014 Jin, Ye (CR21) 2021 Huang (CR15) 2023; 19 Feng (CR35) 2019; 12 Rousset-Rouviere (CR8) 2021; 9 Zhao, Zhao (CR38) 2016; 17 Tian (CR7) 2020; 21 Zhang (CR2) 2021; 13 Lee, Tan, Oon (CR26) 2018; 834 Zhou (CR19) 2022; 13 Zhang, Wang, Xue (CR23) 2022; 2022 Pu (CR18) 2017; 17 Lan (CR27) 2021 Sarkar (CR33) 2021; 29 Sung (CR4) 2021; 71 Gurden, Anderhub, Faisal, Linardopoulos (CR11) 2018; 9 Hahn (CR24) 2016; 55 López-Janeiro (CR43) 2022; 258 Yang (CR20) 2015; 32 Benzi (CR12) 2020; 21 Wang (CR1) 2021; 100 CR6 Suijkerbuijk (CR31) 2010; 70 de Voer (CR37) 2013; 145 CR5 Jiang (CR10) 2021; 40 Maguid, Gabal, Abou Fandoud (CR39) 2023; 24 Shichiri (CR34) 2002; 62 Li (CR41) 2016; 17 Skowyra, Allan, Saurin, Clarke (CR13) 2018; 23 Grabsch (CR17) 2003; 200 Kops, Weaver, Cleveland (CR42) 2005; 5 Qin (CR22) 2021; 60 Biffi, Tuveson (CR25) 2021; 101 Jiao (CR36) 2021; 12 Zhang, Zhang (CR40) 2020; 17 Li, Wan (CR44) 2020; 24 Bolanos-Garcia, Blundell (CR14) 2011; 36 Kim, Gartner (CR16) 2021; 25 Zhu (CR3) 2022; 2022 Cohen-Sharir (CR28) 2021; 590 W Qin (67528_CR22) 2021; 60 M Shichiri (67528_CR34) 2002; 62 M Pu (67528_CR18) 2017; 17 Q Zhu (67528_CR3) 2022; 2022 MS Maguid (67528_CR39) 2023; 24 Q Zhang (67528_CR23) 2022; 2022 YT Lee (67528_CR26) 2018; 834 RM de Voer (67528_CR37) 2013; 145 67528_CR5 JH Teixeira (67528_CR32) 2014; 2014 GM Pierantoni (67528_CR29) 2015; 6 67528_CR6 Y Zhang (67528_CR40) 2020; 17 GJ Kops (67528_CR42) 2005; 5 Y Cohen-Sharir (67528_CR28) 2021; 590 Y Yang (67528_CR20) 2015; 32 A Skowyra (67528_CR13) 2018; 23 MD Gurden (67528_CR11) 2018; 9 H Lan (67528_CR27) 2021 H Feng (67528_CR35) 2019; 12 X Zhou (67528_CR19) 2022; 13 VM Bolanos-Garcia (67528_CR14) 2011; 36 B Li (67528_CR41) 2016; 17 N Wang (67528_CR1) 2021; 100 BL Li (67528_CR44) 2020; 24 K Huang (67528_CR15) 2023; 19 H Grabsch (67528_CR17) 2003; 200 SJ Suijkerbuijk (67528_CR31) 2010; 70 S Wu (67528_CR45) 2021; 36 H Sung (67528_CR4) 2021; 71 CY Jiao (67528_CR36) 2021; 12 W Tian (67528_CR7) 2020; 21 MM Hahn (67528_CR24) 2016; 55 RA Brooks (67528_CR9) 2019; 69 Á López-Janeiro (67528_CR43) 2022; 258 T Kim (67528_CR16) 2021; 25 W Jin (67528_CR21) 2021 S Sarkar (67528_CR33) 2021; 29 G Biffi (67528_CR25) 2021; 101 G Benzi (67528_CR12) 2020; 21 T Zhang (67528_CR2) 2021; 13 S Rousset-Rouviere (67528_CR8) 2021; 9 M Zhao (67528_CR38) 2016; 17 A Gemma (67528_CR30) 2000; 29 N Jiang (67528_CR10) 2021; 40
References_xml	– volume: 258 start-page: 426 year: 2022 end-page: 436 ident: CR43 article-title: The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients publication-title: J. Pathol. doi: 10.1002/path.6012 – volume: 13 start-page: 9157 year: 2021 end-page: 9165 ident: CR2 article-title: PD-L1 expression in endometrial serous carcinoma and its prognostic significance publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S337271 – year: 2021 ident: CR21 article-title: KIF4A knockdown suppresses ovarian cancer cell proliferation and induces apoptosis by downregulating BUB1 expression publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2021.12155 – volume: 36 start-page: 141 year: 2011 end-page: 150 ident: CR14 article-title: BUB1 and BUBR1: Multifaceted kinases of the cell cycle publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2010.08.004 – volume: 17 start-page: 532 issue: Suppl 7 year: 2016 ident: CR38 article-title: Concordance of copy number loss and down-regulation of tumor suppressor genes: A pan-cancer study publication-title: BMC Genomics doi: 10.1186/s12864-016-2904-y – volume: 24 start-page: 1797 year: 2023 end-page: 1808 ident: CR39 article-title: Prostate-specific membrane antigen (PSMA) expression in the neovasculature of high grade gliomas (histopathological and immunohistochemical study) publication-title: Asian Pac. J. Cancer Prev. doi: 10.31557/APJCP.2023.24.5.1797 – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: CR4 article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 – volume: 36 start-page: 934 year: 2021 end-page: 940 ident: CR45 article-title: The role of BUB1B in immune cells and prognosis of renal clear cell carcinoma publication-title: Northwest J. Pharm. – volume: 24 start-page: 7767 year: 2020 end-page: 7777 ident: CR44 article-title: Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.15408 – volume: 9 start-page: 632 year: 2021 ident: CR8 article-title: Endometrial carcinoma: Immune microenvironment and emerging treatments in immuno-oncology publication-title: Biomedicines doi: 10.3390/biomedicines9060632 – volume: 5 start-page: 773 year: 2005 end-page: 785 ident: CR42 article-title: On the road to cancer: Aneuploidy and the mitotic checkpoint publication-title: Nat. Rev. Cancer. doi: 10.1038/nrc1714 – volume: 40 start-page: 378 year: 2021 ident: CR10 article-title: BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-021-02179-z – volume: 23 start-page: 852 year: 2018 end-page: 865 ident: CR13 article-title: USP9X limits mitotic checkpoint complex turnover to strengthen the spindle assembly checkpoint and guard against chromosomal instability publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.03.100 – volume: 12 start-page: 35 year: 2019 ident: CR35 article-title: Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis publication-title: J. Ovarian Res. doi: 10.1186/s13048-019-0508-2 – volume: 69 start-page: 258 year: 2019 end-page: 279 ident: CR9 article-title: Current recommendations and recent progress in endometrial cancer publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21561 – volume: 100 start-page: e27305 year: 2021 ident: CR1 article-title: Identification of risk factors for the prognosis of Chinese patients with endometrial carcinoma publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000027305 – ident: CR6 – volume: 21 start-page: 1136 year: 2020 end-page: 1144 ident: CR7 article-title: The oncogenic role of SOX8 in endometrial carcinoma publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2020.1840318 – volume: 200 start-page: 16 year: 2003 end-page: 22 ident: CR17 article-title: Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer–association with tumour cell proliferation publication-title: J. Pathol. doi: 10.1002/path.1324 – volume: 21 start-page: e50257 year: 2020 ident: CR12 article-title: A common molecular mechanism underlies the role of Mps1 in chromosome biorientation and the spindle assembly checkpoint publication-title: EMBO Rep. doi: 10.15252/embr.202050257 – volume: 590 start-page: 486 year: 2021 end-page: 491 ident: CR28 article-title: Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition publication-title: Nature doi: 10.1038/s41586-020-03114-6 – volume: 2022 start-page: 5721630 year: 2022 ident: CR3 article-title: SPOP inhibition of endometrial carcinoma and its clinicopathological relationship publication-title: Appl. Bionics Biomech. doi: 10.1155/2022/5721630 – volume: 6 start-page: 17342 year: 2015 end-page: 17353 ident: CR29 article-title: Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes publication-title: Oncotarget doi: 10.18632/oncotarget.3944 – volume: 12 start-page: 63 year: 2021 ident: CR36 article-title: BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways publication-title: Cell Death Dis. doi: 10.1038/s41419-020-03234-x – volume: 25 start-page: 1 year: 2021 end-page: 10 ident: CR16 article-title: Bub1 kinase in the regulation of mitosis publication-title: Anim. Cells Syst. (Seoul) doi: 10.1080/19768354.2021.1884599 – volume: 60 start-page: 983 year: 2021 end-page: 994 ident: CR22 article-title: Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis publication-title: Taiwan. J. Obstet. Gynecol. doi: 10.1016/j.tjog.2021.09.007 – volume: 70 start-page: 4891 year: 2010 end-page: 4900 ident: CR31 article-title: Molecular causes for BUBR1 dysfunction in the human cancer predisposition syndrome mosaic variegated aneuploidy publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-4319 – volume: 17 start-page: 2201 year: 2017 end-page: 2204 ident: CR18 article-title: Influence of Bub1 gene on the cell proliferation, cell cycle and apoptosis in human hepatocellular carcinoma cell line MHCC97-H publication-title: Prog. Mod. Biomed. – volume: 145 start-page: 544 year: 2013 end-page: 547 ident: CR37 article-title: Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.06.001 – volume: 29 start-page: 131 year: 2021 end-page: 144 ident: CR33 article-title: Mitotic checkpoint defects: En route to cancer and drug resistance publication-title: Chromosome Res. doi: 10.1007/s10577-020-09646-x – volume: 29 start-page: 213 year: 2000 end-page: 218 ident: CR30 article-title: Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer publication-title: Genes Chromosom. Cancer doi: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1027>3.0.CO;2-G – volume: 834 start-page: 188 year: 2018 end-page: 196 ident: CR26 article-title: Molecular targeted therapy: Treating cancer with specificity publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2018.07.034 – volume: 9 start-page: 19525 year: 2018 end-page: 19542 ident: CR11 article-title: Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: A key role for Aurora B in mitosis publication-title: Oncotarget doi: 10.18632/oncotarget.10657 – volume: 19 start-page: e1011122 year: 2023 ident: CR15 article-title: Inferring evolutionary trajectories from cross-sectional transcriptomic data to mirror lung adenocarcinoma progression publication-title: PLoS Comput Biol. doi: 10.1371/journal.pcbi.1011122 – volume: 101 start-page: 147 year: 2021 end-page: 176 ident: CR25 article-title: Diversity and Biology of Cancer-Associated Fibroblasts publication-title: Physiol. Rev. doi: 10.1152/physrev.00048.2019 – year: 2021 ident: CR27 publication-title: Biosci. Rep. doi: 10.1042/BSR20211719 – volume: 62 start-page: 13 year: 2002 end-page: 17 ident: CR34 article-title: Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival publication-title: Cancer Res. – ident: CR5 – volume: 55 start-page: 855 year: 2016 end-page: 863 ident: CR24 article-title: Prevalence of germline mutations in the spindle assembly checkpoint gene BUB1B in individuals with early-onset colorectal cancer publication-title: Genes Chromosom. Cancer doi: 10.1002/gcc.22385 – volume: 13 start-page: 2471 year: 2022 end-page: 2485 ident: CR19 article-title: BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B) promotes lung adenocarcinoma by interacting with zinc finger protein ZNF143 and regulating glycolysis publication-title: Bioengineered doi: 10.1080/21655979.2021.2013108 – volume: 32 start-page: 81 year: 2015 ident: CR20 article-title: BUB1B promotes multiple myeloma cell proliferation through CDC20/CCNB axis publication-title: Med. Oncol. doi: 10.1007/s12032-015-0542-x – volume: 2014 start-page: 145289 year: 2014 ident: CR32 article-title: An overview of the spindle assembly checkpoint status in oral cancer publication-title: BioMed Res. Int. doi: 10.1155/2014/145289 – volume: 2022 start-page: 3217248 year: 2022 ident: CR23 article-title: ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as diagnostic and prognostic biomarkers in endometrial carcinoma publication-title: Genet. Res. (Camb) doi: 10.1155/2022/3217248 – volume: 17 start-page: 807 year: 2020 end-page: 821 ident: CR40 article-title: The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-020-0488-6 – volume: 17 start-page: 174 year: 2016 ident: CR41 article-title: Comprehensive analyses of tumor immunity: implications for cancer immunotherapy publication-title: Genome Biol. doi: 10.1186/s13059-016-1028-7 – ident: 67528_CR5 – volume: 834 start-page: 188 year: 2018 ident: 67528_CR26 publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2018.07.034 – volume: 25 start-page: 1 year: 2021 ident: 67528_CR16 publication-title: Anim. Cells Syst. (Seoul) doi: 10.1080/19768354.2021.1884599 – volume: 62 start-page: 13 year: 2002 ident: 67528_CR34 publication-title: Cancer Res. – volume: 60 start-page: 983 year: 2021 ident: 67528_CR22 publication-title: Taiwan. J. Obstet. Gynecol. doi: 10.1016/j.tjog.2021.09.007 – volume: 200 start-page: 16 year: 2003 ident: 67528_CR17 publication-title: J. Pathol. doi: 10.1002/path.1324 – volume: 17 start-page: 532 issue: Suppl 7 year: 2016 ident: 67528_CR38 publication-title: BMC Genomics doi: 10.1186/s12864-016-2904-y – volume: 9 start-page: 19525 year: 2018 ident: 67528_CR11 publication-title: Oncotarget doi: 10.18632/oncotarget.10657 – volume: 2022 start-page: 5721630 year: 2022 ident: 67528_CR3 publication-title: Appl. Bionics Biomech. doi: 10.1155/2022/5721630 – volume: 36 start-page: 141 year: 2011 ident: 67528_CR14 publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2010.08.004 – volume: 145 start-page: 544 year: 2013 ident: 67528_CR37 publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.06.001 – year: 2021 ident: 67528_CR27 doi: 10.1042/BSR20211719 – volume: 2014 start-page: 145289 year: 2014 ident: 67528_CR32 publication-title: BioMed Res. Int. doi: 10.1155/2014/145289 – volume: 55 start-page: 855 year: 2016 ident: 67528_CR24 publication-title: Genes Chromosom. Cancer doi: 10.1002/gcc.22385 – year: 2021 ident: 67528_CR21 publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2021.12155 – volume: 12 start-page: 35 year: 2019 ident: 67528_CR35 publication-title: J. Ovarian Res. doi: 10.1186/s13048-019-0508-2 – volume: 36 start-page: 934 year: 2021 ident: 67528_CR45 publication-title: Northwest J. Pharm. – volume: 32 start-page: 81 year: 2015 ident: 67528_CR20 publication-title: Med. Oncol. doi: 10.1007/s12032-015-0542-x – volume: 40 start-page: 378 year: 2021 ident: 67528_CR10 publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-021-02179-z – volume: 23 start-page: 852 year: 2018 ident: 67528_CR13 publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.03.100 – volume: 13 start-page: 2471 year: 2022 ident: 67528_CR19 publication-title: Bioengineered doi: 10.1080/21655979.2021.2013108 – volume: 17 start-page: 2201 year: 2017 ident: 67528_CR18 publication-title: Prog. Mod. Biomed. – volume: 24 start-page: 7767 year: 2020 ident: 67528_CR44 publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.15408 – volume: 21 start-page: 1136 year: 2020 ident: 67528_CR7 publication-title: Cancer Biol. Ther. doi: 10.1080/15384047.2020.1840318 – volume: 19 start-page: e1011122 year: 2023 ident: 67528_CR15 publication-title: PLoS Comput Biol. doi: 10.1371/journal.pcbi.1011122 – volume: 70 start-page: 4891 year: 2010 ident: 67528_CR31 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-4319 – volume: 2022 start-page: 3217248 year: 2022 ident: 67528_CR23 publication-title: Genet. Res. (Camb) doi: 10.1155/2022/3217248 – ident: 67528_CR6 – volume: 24 start-page: 1797 year: 2023 ident: 67528_CR39 publication-title: Asian Pac. J. Cancer Prev. doi: 10.31557/APJCP.2023.24.5.1797 – volume: 17 start-page: 807 year: 2020 ident: 67528_CR40 publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-020-0488-6 – volume: 100 start-page: e27305 year: 2021 ident: 67528_CR1 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000027305 – volume: 590 start-page: 486 year: 2021 ident: 67528_CR28 publication-title: Nature doi: 10.1038/s41586-020-03114-6 – volume: 69 start-page: 258 year: 2019 ident: 67528_CR9 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21561 – volume: 6 start-page: 17342 year: 2015 ident: 67528_CR29 publication-title: Oncotarget doi: 10.18632/oncotarget.3944 – volume: 5 start-page: 773 year: 2005 ident: 67528_CR42 publication-title: Nat. Rev. Cancer. doi: 10.1038/nrc1714 – volume: 21 start-page: e50257 year: 2020 ident: 67528_CR12 publication-title: EMBO Rep. doi: 10.15252/embr.202050257 – volume: 17 start-page: 174 year: 2016 ident: 67528_CR41 publication-title: Genome Biol. doi: 10.1186/s13059-016-1028-7 – volume: 71 start-page: 209 year: 2021 ident: 67528_CR4 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 – volume: 29 start-page: 131 year: 2021 ident: 67528_CR33 publication-title: Chromosome Res. doi: 10.1007/s10577-020-09646-x – volume: 258 start-page: 426 year: 2022 ident: 67528_CR43 publication-title: J. Pathol. doi: 10.1002/path.6012 – volume: 9 start-page: 632 year: 2021 ident: 67528_CR8 publication-title: Biomedicines doi: 10.3390/biomedicines9060632 – volume: 101 start-page: 147 year: 2021 ident: 67528_CR25 publication-title: Physiol. Rev. doi: 10.1152/physrev.00048.2019 – volume: 12 start-page: 63 year: 2021 ident: 67528_CR36 publication-title: Cell Death Dis. doi: 10.1038/s41419-020-03234-x – volume: 13 start-page: 9157 year: 2021 ident: 67528_CR2 publication-title: Cancer Manag. Res. doi: 10.2147/CMAR.S337271 – volume: 29 start-page: 213 year: 2000 ident: 67528_CR30 publication-title: Genes Chromosom. Cancer doi: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1027>3.0.CO;2-G
SSID	ssj0000529419
Score	2.473709
Snippet	This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint... Abstract This study aimed to evaluate the expression and clinical significance of budding uninhibited by benzimidazole 1 (BUB1) and BUB1 mitotic checkpoint...
SourceID	doaj pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	17084
SubjectTerms	631/114 631/67 Benzimidazoles Bioinformatics Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism BUB1 BUB1B Cancer CD4 antigen CD8 antigen Cell Cycle Proteins Cell Line, Tumor Cell migration Cell Movement - genetics Clinicopathological characteristics Development Disease-Free Survival Endometrial cancer Endometrial Neoplasms - genetics Endometrial Neoplasms - mortality Endometrial Neoplasms - pathology Endometrium Endothelial cells Female Gene expression Gene Expression Regulation, Neoplastic Humanities and Social Sciences Humans Immunotherapy Infiltration Kinases Lymphocytes T Medical prognosis Metastases Middle Aged multidisciplinary Phenotypes Prognosis Protein Serine-Threonine Kinases - genetics Protein Serine-Threonine Kinases - metabolism Protein-serine/threonine kinase Science Science (multidisciplinary) siRNA Uterine cancer
SummonAdditionalLinks	– databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtQw0IICEhfej0BBQeIGVh3bie0TYisqTlUPFPVm2bENK5WkbLZI_D0zTjar5dELh0hR7CiezIxnPE9CXhvvK5YqOKmmUFMplKIOkEGl9FwFLkLlQm42oY6P9dmZOZkMbsMUVrnZE_NGHfoWbeQHgmkJRxWh5LuL7xS7RqF3dWqhcZ3cwCoJIofuncw2FvRiycpMuTJM6IMB5BXmlHFJQVPmQCQ78iiX7f-brvlnyORvftMsjo7u_i8g98idSREt34-Uc59ci90DcmtsTfnzIfl8iG07xkC5sk_l4nRRla4L-WZRovm2BN2xDNugozyM8V5dPywHfCl2of8Wc2OQskXyWj0ip0cfPh1-pFMPBtrWslpT7piIdSMaL7wwMrpGp4RJJSml6FVdOy5V0BH0uCroNtbJNyB3FWt0UCZU4jHZ6_ouPiUllpkR0SnjIqgtLWb8ugT7Po9wZDKsLki1wYRtpwLl2Cfj3GZHudB2xJ4F7NmMPcsL8mZ-52Isz3Hl7AUieJ6JpbXzg371xU6caj0HImWildrhxZ02QXpTh1Z5I3xTkP0NXu3E74PdIrUgr-Zh4FR0v7gu9pfjHNWAug2QPhmpaV4JwC91I01B9A6d7Sx1d6Rbfs3VwDEHzCgGH367Icntuv79L55dDcZzcpsjlzBFudwne-vVZXxBbrY_1sth9TKz2S8Aty2F priority: 102 providerName: ProQuest
Title	Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer
URI	https://link.springer.com/article/10.1038/s41598-024-67528-2 https://www.ncbi.nlm.nih.gov/pubmed/39048649 https://www.proquest.com/docview/3084107374 https://www.proquest.com/docview/3084767745 https://pubmed.ncbi.nlm.nih.gov/PMC11269704 https://doaj.org/article/b227d03c48ac48a2a89d4b95dc7b93b6
Volume	14
WOSCitedRecordID	wos001276798400030&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dj9QgECd6p8m9GL-tnhtMfNPmWqAFHu3lLvpwm8Z4Zn0iUCBuoq3Z7l3if-8A3b1bP1986KQpkMIwlJky8xuEXkpjysKXYKl6W-WMcp5rmIycMUO4JdSW2sZkE3w-F4uFbK-l-go-YQkeODHuyBBoU9COCR0uooW0zMjKdtxIaiLYNmg914yphOpNJCvlFCVTUHE0wk4VoskIy0FHJiAeOztRBOz_nZb5q7PkTyemcSM6vYvuTBokfpN6fg_dcP19dDvllPz-AH08Dvk2kocbHjxuzpsS697GmwaH_64YlD5sr7yFYnFw1OqHcTmGRq63w1cXM3rgLsjF6iE6Pz35cPw2n5In5F3FynVOdEFdVdPaUEMlc7oW3odoEO-9M7yqNGHcCgcKWGlF5ypvatgweVELy6Ut6SO01w-9e4JwwIehTnOpHegbXQjV1R4-2MSBrSOLKkPlhpGqm5DFQ4KLLyqecFOhEvMVMF9F5iuSoVfbNt8SrsZfazdhfrY1AyZ2fACSoiZJUf-SlAwdbmZXTQt1VLQQDCxgylmGXmyLYYmFcxPdu-Ei1eE16Mkw0sdJGLY9gfEzUTOZIbEjJjtd3S3pl58jjHcI3pK8gBe_3kjUVb_-zIun_4MXz9ABCUuh4Dlhh2hvvbpwz9Gt7nK9HFczdJMveKRihvabk3n7fhbXF9Az0gbKge63787aTz8AiBAm9w
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKAcGFfRkoECQ4QdTEdmL7gBBTqFq1jHpoUW_Gjh06UknKZArqn-I38p6zjIaltx44jBSNncSOv7fZbyHkhbI2TcoULNXSZTFnQsQGFiPm3FLhKHOpcaHYhJhM5OGh2lshP_tYGHSr7HliYNSuLnCPfJ0lkoOpwgR_e_ItxqpReLral9BoYbHjz36Ayda82X4P6_uS0s0P-xtbcVdVIC4yns5jahLms5zlllmmuDe5LEsMkyjL0luRZYZy4aQHzSR1svBZaXOQJCLJpRPKpQyee4lcBjWCyuAquDfs6eCpGU9VF5uTMLnegHzEGDbKY9DMKYBySf6FMgF_023_dNH87Zw2iL_Nm__bh7tFbnSKdvSupYzbZMVXd8jVtvTm2V3yaQPLkrSOgFFdRuODcRqZyoWLcYTb0xHoxpFbOFWFZvRnq-pm2uBNvnL1Vx8Kn0QFks_sHjm4kEndJ6tVXfmHJMI0OswboYwHtazAiGZTglyjHkxClWQjkvYrr4suATvWATnWwRGASd2iRQNadECLpiPyarjnpE0_cm7vMQJq6Impw8Mf9eyL7jiRthSIMGEFlwZ_1EjluFWZK4RVzOYjstbjSHf8rNELEI3I86EZOBEeL5nK16dtH5GDOQEzfdCidxgJzJ_LnKsRkUu4Xhrqcks1PQrZzjHGTYkEXvy6J4HFuP79LR6dP41n5NrW_sddvbs92XlMrlOk0ETElK-R1fns1D8hV4rv82kzexpIPCKfL5o0fgF1iouQ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKgYoL-zJQIEhwgmgS24ntA0JMy4iqaDQHinpzndimI0FSJlNQ_xq_jvecZEbD0lsPHCJFsZPYyfc2-y2EPFdFkSY-BUvV2yzmTIjYwM-IOS-osJTZ1NhQbEJMJvLwUE03yM8-FgbdKnueGBi1rUtcIx-yRHIwVZjgQ9-5RUx3x29OvsVYQQp3WvtyGi1E9t3ZDzDfmtd7u_CvX1A6fvdx533cVRiIy4yni5iahLksZ3nBCqa4M7n0HkMmvPeuEFlmKBdWOtBSUitLl_kiB6kiklxaoWzK4LmXyGWBScuD2-B0ub6DO2g8VV2cTsLksAFZifFslMegpVMA6JosDCUD_qbn_umu-duebRCF4xv_80e8Sa53Cnj0tqWYW2TDVbfJ1bYk59kd8mkHy5W0DoJR7aPRwSiNTGXDySjCZesIdObIrpytQjP6uVV1M2vwJlfZ-qsLBVGiEslqfpccXMik7pHNqq7cAxJheh3mjFDGgbpWYqSz8SDvqANTUSXZgKQ9CnTZJWbH-iBfdHAQYFK3yNGAHB2Qo-mAvFzec9KmJTm39wjBteyJKcXDhXr-WXccShcUiDNhJZcGD2qksrxQmS1FoViRD8h2jynd8blGrwA1IM-WzcChcNvJVK4-bfuIHMwMmOn9FsnLkcD8ucy5GhC5hvG1oa63VLPjkAUdY9-USODFr3pyWI3r39_i4fnTeEq2gCL0h73J_iNyjSKxJiKmfJtsLuan7jG5Un5fzJr5k0DtETm6aMr4BWv6lE0
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+of+BUB1+and+BUB1B+with+the+development+and+prognosis+of+endometrial+cancer&rft.jtitle=Scientific+reports&rft.au=Zhang%2C+Huicong&rft.au=Li%2C+Yuhao&rft.au=Lu%2C+Huixia&rft.date=2024-07-24&rft.eissn=2045-2322&rft.volume=14&rft.issue=1&rft.spage=17084&rft_id=info:doi/10.1038%2Fs41598-024-67528-2&rft_id=info%3Apmid%2F39048649&rft.externalDocID=39048649
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon